Thalys(SH:603716) Zheng Xing Xing Ye Ri Bao·2025-09-02 08:59Market Overview - The pharmaceutical commercial sector experienced a slight decline of 0.1% on September 2, with Saily Medical leading the drop [1] - The Shanghai Composite Index closed at 3858.13, down 0.45%, while the Shenzhen Component Index closed at 12553.84, down 2.14% [1] Stock Performance - Yifeng Pharmacy (603939) saw a significant increase of 3.87%, closing at 24.42 with a trading volume of 272,000 shares and a turnover of 656 million [1] - First Pharmaceutical (600833) rose by 3.70%, closing at 15.13 with a trading volume of 471,400 shares and a turnover of 736 million [1] - Saily Medical (603716) led the decline with a drop of 8.89%, closing at 30.55, with a trading volume of 434,900 shares and a turnover of 1.351 billion [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 384 million from institutional investors, while retail investors experienced a net inflow of 288 million [2] - The data indicates that speculative funds had a net inflow of approximately 95.77 million [2] Individual Stock Capital Flow - Shanghai Pharmaceuticals (601607) had a net inflow of 24.77 million from institutional investors, but a net outflow of 34.79 million from retail investors [3] - Nanjing Pharmaceutical (600713) experienced a net inflow of 19.98 million from institutional investors, with a net outflow of 32.21 million from retail investors [3] - People's Tongtai (600829) had a net inflow of 16.78 million from institutional investors, but a net outflow of 14.47 million from retail investors [3]